Skip to main content
Twitter
LinkedIn
Email
About
Company
Hydrogel Technology
Leadership
Management Team
Board of Directors
Scientific Advisors
Clinical Trials
Contact Us
Pipeline
Retinal Diseases
OTX-TKI (axitinib intravitreal implant)
Glaucoma
OTX-TIC (travoprost intracameral implant)
Dry Eye Disease
OTX-CSI (cyclosporine intracanalicular insert)
OTX-DED (dexamethasone intracanalicular insert)
Products
DEXTENZA
®
(dexamethasone ophthalmic insert)
Postsurgical Ocular Inflammation and Pain
Ocular Itching Associated with Allergic Conjunctivitis
ReSure
®
Sealant
Investors
Press Releases
Events and Presentations
Upcoming & Past Events
Investor & Corporate Presentations
Scientific & Medical Presentations
SEC Filings
Corporate Governance
Board of Directors
Committee Composition
Stock Information
Analyst Coverage
Historical Price Lookup
Investment Calculator
Investor FAQs
Information Request
Careers
Culture and Values
Benefits
Open Positions
Search
Site Map
Site Map
Ocular Therapeutix
About
Company
Hydrogel Technology
Leadership
Contact Us
SCIENTIFIC ADVISORS
BOARD OF DIRECTORS
MANAGEMENT TEAM
Research
Pipeline
OTX-TIC (travoprost intracameral implant)
OTX-TKI (axitinib intravitreal implant)
Clinical Trials
OTX-CSI (cyclosporine intracanalicular insert)
OTX-DED (dexamethasone intracanalicular insert)
Products
DEXTENZA
®
(dexamethasone ophthalmic insert)
ReSure
®
Sealant
DEXTENZA
®
(dexamethasone ophthalmic insert) AC
Investors
Careers
Core Values + Benefits
Benefits
Company Culture and Values
Search
Privacy Policy
Terms and Conditions of Use
MEDICAL INQUIRIES
Social Media Consent
clinicaltrialsOTX-TIC
Clinical Trial Contact Form
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset